This ABCA7 variant is associated with a later age of onset and shorter disease process (Karch et al., 2012; Zhao et al., 2015), exacerbating cognitive decline in subjects diagnosed with mild cognitive impairment or AD (Carrasquillo et al., 2015). This evidence concerns the gene ABCA7 and Alzheimer disease.